|
C5ORF24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.427870E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.866400E-02 |
| Normal-vs-Stage2 |
1.438760E-01 |
| Normal-vs-Stage3 |
3.059900E-03 |
| Normal-vs-Stage4 |
5.763000E-04 |
| Stage1-vs-Stage2 |
9.034400E-01 |
| Stage1-vs-Stage3 |
1.452020E-01 |
| Stage1-vs-Stage4 |
5.958200E-02 |
| Stage2-vs-Stage3 |
2.586600E-01 |
| Stage2-vs-Stage4 |
9.779900E-02 |
| Stage3-vs-Stage4 |
4.423800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.656500E-02 |
| Normal-vs-AfricanAmerican |
3.900000E-01 |
| Normal-vs-Asian |
1.184480E-02 |
| Caucasian-vs-AfricanAmerican |
4.227600E-01 |
| Caucasian-vs-Asian |
5.744200E-01 |
| AfricanAmerican-vs-Asian |
2.665000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.895800E-03 |
| Normal-vs-Female |
3.093700E-02 |
| Male-vs-Female |
2.197600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.043800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.381300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.676500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.341600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.240400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.080770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.466000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.031000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.194400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.393200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.141500E-02 |
| Classical-VS-Follicular |
1.794960E-01 |
| Classical-VS-Other |
2.761000E-01 |
| Classical-VS-Normal |
8.822500E-02 |
| Tall-VS-Follicular |
6.299000E-01 |
| Tall-VS-Other |
6.070200E-01 |
| Tall-VS-Normal |
7.862100E-03 |
| Follicular-VS-Other |
5.146400E-01 |
| Follicular-VS-Normal |
1.162190E-02 |
| Other-VS-Normal |
5.210000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.755700E-03 |
| Normal-vs-N1 |
7.897600E-03 |
| N0-vs-N1 |
6.082800E-01 |
|
|
